<table id="ID150" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 15. Summary of Drug Interactions With Lamotrigine</caption>
<col span="1" width="38%"></col>
<col span="1" width="30%"></col>
<col span="1" width="32%"></col>
<tbody>
<tr>
<td>
<content stylecode="bold">Drug</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td>
<content stylecode="bold">Drug </content>
<content stylecode="bold">Plasma </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">With </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Adjunctive </content>
<content stylecode="bold">Lamotrigine<sup>a</sup>
</content>
<content stylecode="bold">
<br/>
</content>
</td>
<td>
<content stylecode="bold">Lamotrigine </content>
<content stylecode="bold">Plasma </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Concentration </content>
<content stylecode="bold">With </content>
<content stylecode="bold">
<br/>
</content>
<content stylecode="bold">Adjunctive </content>
<content stylecode="bold">Drugs<sup>b</sup> </content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
<tr>
<td>Oral contraceptives <br/>(e.g. ethinylestradiol/levonorgestrel)<sup>c</sup>
</td>
<td>↔<sup>d</sup>
<br/>
</td>
<td>↓<br/>
</td>
</tr>
<tr>
<td>Bupropion</td>
<td>Not assessed<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Carbamazepine (CBZ)<br/>
</td>
<td>↔<br/>
</td>
<td>↓<br/>
</td>
</tr>
<tr>
<td>CBZ epoxide<sup>e</sup>
</td>
<td>?<br/>
</td>
<td>
<br/>
</td>
</tr>
<tr>
<td>Felbamate<br/>
</td>
<td>Not assessed<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Gabapentin<br/>
</td>
<td>Not assessed<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Levetiracetam<br/>
</td>
<td>↔<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Lithium<br/>
</td>
<td>↔<br/>
</td>
<td>Not assessed<br/>
</td>
</tr>
<tr>
<td>Olanzapine<br/>
</td>
<td>↔<br/>
</td>
<td>↔<sup>f</sup>
<br/>
</td>
</tr>
<tr>
<td>Oxcarbazepine<br/>
</td>
<td>↔<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>10-monohydroxy oxcarbazepine metabolite<sup>g</sup>
</td>
<td>↔<br/>
</td>
<td>
<br/>
</td>
</tr>
<tr>
<td>Phenobarbital/primidone<br/>
</td>
<td>↔<br/>
</td>
<td>↓<br/>
</td>
</tr>
<tr>
<td>Phenytoin (PHT)<br/>
</td>
<td>↔<br/>
</td>
<td>↓<br/>
</td>
</tr>
<tr>
<td>Pregabalin<br/>
</td>
<td>↔<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Rifampin<br/>
</td>
<td>Not assessed<br/>
</td>
<td>↓<br/>
</td>
</tr>
<tr>
<td>Topiramate<br/>
</td>
<td>↔<sup>h</sup>
<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Valproate<br/>
</td>
<td>↓<br/>
</td>
<td>↑<br/>
</td>
</tr>
<tr>
<td>Valproate + PHT and/or CBZ<br/>
</td>
<td>Not assessed<br/>
</td>
<td>↔<br/>
</td>
</tr>
<tr>
<td>Zonisamide<br/>
</td>
<td>Not assessed<br/>
</td>
<td>↔<br/>
</td>
</tr>
</tbody>
</table>